scispace - formally typeset
Search or ask a question
Institution

Monash University

EducationMelbourne, Victoria, Australia
About: Monash University is a education organization based out in Melbourne, Victoria, Australia. It is known for research contribution in the topics: Population & Poison control. The organization has 35920 authors who have published 100681 publications receiving 3027002 citations.


Papers
More filters
Journal ArticleDOI
22 Dec 1967-Science
TL;DR: The adsorption of antibody to polymeric surfaces has been used to develop a new method of solid-phase radioimmunoassay that is simple, rapid, inexpensive, and suitable for automation.
Abstract: The adsorption of antibody to polymeric surfaces has been used to develop a new method of solid-phase radioimmunoassay. Incubation is performed in antibody-coated, disposable tubes that are finally washed-out with water and counted for quantitation of the bound tracer. The method is simple, rapid, inexpensive, and suitable for automation.

566 citations

Journal ArticleDOI
TL;DR: In this paper, the authors examined place attachment as a second-order factor and investigated its relationship with place satisfaction and visitors' low and high effort pro-environmental behavioural intentions.

565 citations

Journal ArticleDOI
TL;DR: These results indicate that simple linear regression of regional fMRI time series against head motion parameters and WM/CSF signals (with or without expansion terms) is not sufficient to remove head motion artefacts, and group comparisons in functional connectivity between healthy controls and schizophrenia patients are highly dependent on preprocessing strategy.

564 citations

Journal ArticleDOI
TL;DR: The Concise Guide to PHARMACOLOGY 2017/18 provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
Abstract: The Concise Guide to PHARMACOLOGY 2017/18 provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13878/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

563 citations

Journal ArticleDOI
27 Oct 2015-JAMA
TL;DR: Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk of AKI and main secondary outcomes were incidence of RRT use and in-hospital mortality.
Abstract: Importance Saline (0.9% sodium chloride) is the most commonly administered intravenous fluid; however, its use may be associated with acute kidney injury (AKI) and increased mortality. Objective To determine the effect of a buffered crystalloid compared with saline on renal complications in patients admitted to the intensive care unit (ICU). Design and Setting Double-blind, cluster randomized, double-crossover trial conducted in 4 ICUs in New Zealand from April 2014 through October 2014. Three ICUs were general medical and surgical ICUs; 1 ICU had a predominance of cardiothoracic and vascular surgical patients. Participants All patients admitted to the ICU requiring crystalloid fluid therapy were eligible for inclusion. Patients with established AKI requiring renal replacement therapy (RRT) were excluded. All 2278 eligible patients were enrolled; 1152 of 1162 patients (99.1%) receiving buffered crystalloid and 1110 of 1116 patients (99.5%) receiving saline were analyzed. Interventions Participating ICUs were assigned a masked study fluid, either saline or a buffered crystalloid, for alternating 7-week treatment blocks. Two ICUs commenced using 1 fluid and the other 2 commenced using the alternative fluid. Two crossovers occurred so that each ICU used each fluid twice over the 28 weeks of the study. The treating clinician determined the rate and frequency of fluid administration. Main Outcomes and Measures The primary outcome was proportion of patients with AKI (defined as a rise in serum creatinine level of at least 2-fold or a serum creatinine level of ≥3.96 mg/dL with an increase of ≥0.5 mg/dL); main secondary outcomes were incidence of RRT use and in-hospital mortality. Results In the buffered crystalloid group, 102 of 1067 patients (9.6%) developed AKI within 90 days after enrollment compared with 94 of 1025 patients (9.2%) in the saline group (absolute difference, 0.4% [95% CI, −2.1% to 2.9%]; relative risk [RR], 1.04 [95% CI, 0.80 to 1.36]; P = .77). In the buffered crystalloid group, RRT was used in 38 of 1152 patients (3.3%) compared with 38 of 1110 patients (3.4%) in the saline group (absolute difference, −0.1% [95% CI, −1.6% to 1.4%]; RR, 0.96 [95% CI, 0.62 to 1.50]; P = .91). Overall, 87 of 1152 patients (7.6%) in the buffered crystalloid group and 95 of 1110 patients (8.6%) in the saline group died in the hospital (absolute difference, −1.0% [95% CI, −3.3% to 1.2%]; RR, 0.88 [95% CI, 0.67 to 1.17]; P = .40). Conclusions and Relevance Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk of AKI. Further large randomized clinical trials are needed to assess efficacy in higher-risk populations and to measure clinical outcomes such as mortality. Trial Registration clinicaltrials.gov Identifier:ACTRN12613001370796

563 citations


Authors

Showing all 36568 results

NameH-indexPapersCitations
Bert Vogelstein247757332094
Kenneth W. Kinzler215640243944
David J. Hunter2131836207050
David R. Williams1782034138789
Yang Yang1712644153049
Lei Jiang1702244135205
Dongyuan Zhao160872106451
Christopher J. O'Donnell159869126278
Leif Groop158919136056
Mark E. Cooper1581463124887
Theo Vos156502186409
Mark J. Smyth15371388783
Rinaldo Bellomo1471714120052
Detlef Weigel14251684670
Geoffrey Burnstock141148899525
Network Information
Related Institutions (5)
University of New South Wales
153.6K papers, 4.8M citations

97% related

University of Sydney
187.3K papers, 6.1M citations

97% related

University of Queensland
155.7K papers, 5.7M citations

97% related

University of Melbourne
174.8K papers, 6.3M citations

96% related

National University of Singapore
165.4K papers, 5.4M citations

92% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023250
20221,020
20219,402
20208,419
20197,409
20186,437